South African government "could have prevented" 365,000 HIV/AIDS deaths with ARV drugs

1 December 2008

South Africa's government could have prevented the premature deaths of 365,000 people, 35,000 of them babies, in the 2000-2005 period if it had provided antiretroviral drugs to HIV/AIDS patients and adopted viral entry-blockers to help prevent pregnant women from infecting their offspring, according to a new study by US researchers.

The Harvard University report, published in the Journal of Acquired Immune Deficiency Syndromes, concluded that the then President Thabo Mbeki's denial of the viral cause of AIDS was the main cause of the lack of treatment. Mr Mbeki was overthrown by an internal faction fight within the ruling African National Congress in September this year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight